Qingguo Li1, Sanjun Cai1, Ye Xu1, Huixun Jia2, Ji Zhu3
1Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, 2Center for Biomedical Statistical, Fudan University Shanghai Cancer Center, 3Department of Radiation Oncology, Fudan University Shanghai Cancer Center.
Objective:Our aim was to determine impact of
negative to positive lymph node ratio (NPR) on oncological outcomes in a series
of patients with stage III colorectal cancer. Method: This retrospective
study included 2,256 patients with stage III colorectal cancer under curative
resection at Fudan university Shanghai cancer center from January 2007 to
December 2012. Kaplan-Meier methods were adopted and multivariable Cox
regression models were built for the analysis of long-term survival outcomes
and risk factors. Result: X-tile program identified 6 and 2.38 as the
optimal cutoff value for negative lymphnodes (NLN) and NPR to divide the cohort
into high and low risk subsets interms of colorectal cancer cause specific
survival (CCSS). In a multivariate analysis, NPR and NLN were significant
independent prognostic factors for CCSS (P<0.05), notably, N
classification was not an independently prognostic factor (P=0.883).Further
analysis found NPR could stratified both N1 and N2 stage to high and low risk
well (P<0.05).Conversely, N stage couldn't stratified NPR group (P>0.05).Interestingly,
patients in N2+ NPR>2.38 stage have similar survival outcome with N1+ NPR>2.38
stage (χ2=0.030, P=0.863), and better than those at N1+ NPR
≤2.38 and N2+ NPR ≤2.38 stage (P<0.001).The different between N1+ NPR
≤2.38and N2+ NPR ≤2.38 stage was also not significance (χ2=0.290, P=0.590).Conclusion: NPR was an independent prognostic factor for stage III CRC
patients, it could provide more accurate prognostic information than the
current node stage system.
Key
Words: Colorectal Cancer Prognosis analysis Lymph node
Copyright © 1998 - 2024 Chinese Society of Clinical Oncology(CSCO). All Rights Reserved
Contact Us
EMAIL:office@csco.org.cn
international@csco.org.cn
Phone:86(10)67726451 (Beijing)
86(25)84547290 (Nanjing)